4
Changes in Ownership
Zentalis Pharmaceuticals, Inc. Filed Acc 0001838041-26-000002
Options or other derivatives
- Chief Medical Officer acquired 365,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Bruns Ingmar · Chief Medical Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-01-08 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +365,000 | 365,000 | D |
Loading xslF345X05/wk-form4_1768008888.xml…